Lung Cancers Completed Phase 1 Trials for Tanespimycin (DB05134)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004065Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerTreatment